2. UroToday Home
  3. Video Lectures

AUA 2023 Videos

Deep PSA Response Following Addition of Darolutamide to ADT and Docetaxel in ARASENS - Fred Saad
Transgender Women and Prostate Cancer: Revealing an Underestimated Disease Burden - Stephen J. Freedland
DEAR: Comparative Real-World Evidence on Darolutamide, Enzalutamide, and Apalutamide for Patients with nmCRPC in the United States - Neal D. Shore
Immersive Virtual Reality (iVR) for Percutaneous Nephrolithotomy: The More You Know, the Better the Outcome Presentation - Andrei D. Cumpanas
Exploring Leadership, Mentorship, and Sponsorship in Urology - Kirsten L. Greene
Alkaline Water: “Help or Hype” for Uric Acid Stone Patients - Paul Piedras
The Application of Artificial Intelligence for Renal Stone Volume Determination: Ready for Prime Time? - Andrei D. Cumpanas
Exploring Unique Aspects of Prostate Cancer Research in the VA Healthcare System: Diversity, Disparities, and Future Directions - Isla P. Garraway
Exploring Regional Variation in Genomic Testing and Imaging in Prostate Cancer - Michael S. Leapman
Trends in Prostate Cancer Diagnosis in Transgender Women - Farnoosh Nik-Ahd
Fluid Temperature Effect on Superpulse Thulium Fiber Laser Stone Ablation - Andrei D. Cumpanas
Breaking Barriers: Achieving Gender Equity in Urology - Simone Thavaseelan
Exploring the Expanding Role of Advanced Practice Providers in Urologic Oncology - Anne Lizardi-Calvaresi & Sam Chang
The Effect of Visual and Numeric Risk Information on Surgeon Behavior: A Randomized, Clinical Vignette Experiment - Hung-Jui (Ray) Tan
Selecting the Appropriate Urinary Diversion Method for Bladder Cancer Patients - Bernard Bochner & Arnulf Stenzl
Machine Learning's Transformative Potential in Urologic Diagnosis and Care - Diane Newman & Gregory Tasian
Evaluation of Renal Stone and Stent Durability Following Resonance Stent Placement for Benign Disease Presentation - Kelvin Vo
The Effects of 24-Hour Urinary Calcium Oxalate Supersaturation Level on Stone Growth and New Stone Formation: "When To Worry, When to Not" Presentation - Antonio R. H. Gorgen
Exploring Tumor Biomarkers in Urothelial Carcinoma: Insights and Advancements in Bladder Cancer Research - Chad Ritch
Addressing Financial Toxicity in Cancer Care - Benjamin Stone
Understanding Social Vulnerability's Impact on Urologic Cancer Care - Rishi Sekar
The Consortium on Disparities of Urologic Conditions (ConDUC): Addressing Disparities in Urologic Conditions and Clinical Trials for African Americans - Curtis A. Pettaway & Walter Rayford
Optimizing Care of Bladder Cancer in Women - Katie Murray
Breaking Barriers in Urologic Research: Tackling Health Disparities and Collaborative Solutions - Cheryl T. Lee
The TAR-200 Device in Muscle-Invasive Bladder Cancer: Safety, Efficacy, and Future Prospects - Mark D. Tyson, II
Promoting Diversity and Empowering Black Urologists: The R. Frank Jones Urological Society - Linda L. McIntire
Addressing Challenges in Bladder Cancer Surgery: Enhancing Patient Outcomes and Preparing for Recovery - Sarah Psutka
Journal of Urology Open Plus - Revolutionizing Access and Innovation in Urology Research - John W. Davis
Natural History of Ureteral Injury in an In-Vivo Porcine Model Presentation - Sohrab N. Ali
Unveiling the Forces of Ureteroscopy: Investigating Urologists' Impact on Ureteral Injury Presentation - Seyed Amiryaghoub M. Lavasani
Pembrolizumab's Impact on Cystectomy-Free Survival in BCG Unresponsive Bladder Cancer from the KEYNOTE-057 Trial - Girish Kulkarni
Managing Intermediate Risk Bladder Cancer: Treatment Strategies and Surveillance - Paolo Gontero & Gary Steinberg
Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni
Highlighting Bias and Barriers in Urological Care and Prostate Cancer Research - Linda L. McIntire & Tracy M. Downs
Full Data Analysis of the Biology and Performance of Pre- and Post-Pembrolizumab VI-RADS for Predicting Pathological Response in MIBC: Insights from a Comprehensive Clinical Trials Pipeline - Andrea Necchi
Improving Primary Prostate Cancer Diagnosis Through Risk Stratified Screening: a European Perspective - Sigrid Carlsson
TAR-200 in Combination with Cetrelimab for BCG Unresponsive Bladder Cancer (SunRISe-1) - Siamak Daneshmand
Optimizing BCG Therapy in Bladder Cancer: Expert Insights on Managing Toxicity and Maximizing Efficacy - Badrinath Konety & Wassim Kassouf
Gene Therapy and Pembrolizumab in BCG-Unresponsive CIS-Containing Population: Updated Results, Efficacy, and Correlative Studies - Roger Li
En Bloc Resection vs. Standard Resection for Bladder Tumors: Multicenter Trial Results and Clinical Considerations - Jeremy Teoh
Long-Term Survival Outcomes in Patients with BCG Unresponsive Non-Muscle Invasive Bladder Cancer: Evaluating Bladder-Sparing Treatment - Wei Shen Tan
Advancements in Prostate Cancer Screening: Inclusion of At-Risk Groups, Imaging & Biomarkers - An AUA Guidelines Update - Daniel Lin
Risk Assessment in Localized Prostate Cancer - Insights from Real-World Data and SEER Registry - Jim Hu
Safe Passage of a 16 French Ureteral Access Sheath Presentation - Amanda McCormac
AUA Guidelines for Upper Tract Urothelial Carcinoma: Streamlined Approaches and Novel Opportunities for Treatment - Jean Heather Hoffman-Censits
Insights into the AUA Guidelines for Upper Tract Urothelial Carcinoma: Standardizing Diagnosis and Treatment for Better Patient Outcomes - Jonathan A. Coleman
Diversity, Equity & Inclusion in Urology - Larissa Bresler
Expert Panel Discussion on Management of UTUC: Insights on Treatment, Prevention, and Future Directions - Surena Matin, Jay Raman, Sima Porten, and Tomonori Habuchi
Improving Appropriate Utilization of Imaging in Prostate Cancer Patients: A Discussion on the RADAR Articles - E. David Crawford
Advancing Rectal Spacing in Prostate Cancer Radiation Therapy: The Benefits of Barrigel® - Neil Mariados
Clinical Measurement of Maximum Safe Ureteral Distensibility Using a Novel Force Sensor Presentation - Amanda McCormac
Improving MRI for Localized Prostate Cancer Diagnosis: The Need for a Standardized and Quantitative MRI Approach - Tyler Seibert
Optimal TURBT: Do Skilled Urologists Really Need Photodynamic Diagnosis (PDD)? -Trinity Bivalacqua & Michael Cookson
EMBARK Trial Shows Promising Results for High-Risk Prostate Cancer Treatment, Enzalutamide's Impact on Metastasis-Free Survival - Neal Shore
A Pilot Study on the Dark Matter of Clear Cell Renal Cell Carcinoma: The Role of the Urinary Microbiome Presentation - Andrei Dragos Cumpanas
Development and Initial Clinical Experience of a Novel Endoscopic Robotic Platform: Monarch PCNL Presentation - Jaime Landman
Exploring Mentorship and Coaching in Urology: Insights and Strategies for Overcoming Burnout - Angie Smith
The Importance of Implementing Psycho-Oncology Into Prostate Cancer Survivorship - Cristiane Bergerot
Contemporary Techniques in Transurethral Resection of Bladder Tumor, An Educational Course - Max Kates